POINT Heme NGS Panel
Synonyms |
|
Cerner Name |
|
Clinical Info |
This panel is designed to cover major myeloid neoplasms and comprises 45 DNA target genes as well as 34 drivergenes for fusions. It is designed to detect single nucleotide variants (SNVs), insertions and deletions (InDels) andgene fusions using a single workflow for both DNA and RNA derived from peripheral blood or bone marrow specimens. |
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
Specimen Types |
Blood |
Specimen Volume |
2x5 ml of peripheral blood (PB) or bone marrow (BM) |
Container |
Lavender Top Tube |
Collection Instructions |
|
Transport Instructions |
Specimen can be transported at room temperature within 24 hours of collection, or at 4°C, up |
Specimen Stability |
Specimens with a collection date > 7 days will be rejected. |
Methodology |
Next Generation Sequencing (NGS) on the Genexus System |
Days Performed |
Monday - Friday |
Performing Laboratories |
Northwell Health Labs |
CPT |
81450 |
PDM |
258467 |
Results |
|
Result Interpretation |
|
Forms |
|
